I’ve been noticing a dynamic in a bunch of pharma stocks that I follow, where something in their pipeline gets FDA approval, and then the stock price dips significantly. What causes that to happen? Seems counterintuitive, but it’s so common that I feel like there must be some consistent explanation.
Leave a Reply